Brief: Xintela Preclinical Study Results Indicate Disease Modifying Effect Of EQSTEM

Xintela AB

20/12/2023 15:47

Dec 20 (Reuters) - Xintela AB  XINT.ST :
    * PUBLISHES EFFICACY RESULTS WITH EQSTEM FROM PRECLINICAL EQUINE OA STUDY
    * RESULTS DEMONSTRATE LESS PAIN, LESS CARTILAGE DAMAGE AFTER TREATMENT WITH STEM CELL
PRODUCT
EQSTEM
    * RESULTS INDICATE DISEASE MODIFYING EFFECT OF EQSTEM

Source text for Eikon:  ID:nMFN8394hq 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))